BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29755115)

  • 1. Endothelial Akt1 loss promotes prostate cancer metastasis via β-catenin-regulated tight-junction protein turnover.
    Gao F; Alwhaibi A; Artham S; Verma A; Somanath PR
    Br J Cancer; 2018 May; 118(11):1464-1475. PubMed ID: 29755115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
    Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
    Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation.
    Li W; Hou JZ; Niu J; Xi ZQ; Ma C; Sun H; Wang CJ; Fang D; Li Q; Xie SQ
    Cell Commun Signal; 2018 Nov; 16(1):82. PubMed ID: 30445978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis.
    Alwhaibi A; Verma A; Artham S; Adil MS; Somanath PR
    Biochem Pharmacol; 2019 Oct; 168():1-13. PubMed ID: 31202735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing Akt1 enhances the resistance of prostate cancer cells to starvation and inhibits starvation-induced lung metastasis through epithelial-mesenchymal transition in prostate cancer.
    Yang M; Liu H; Qiu GP; Gao F
    Med Oncol; 2021 Nov; 39(1):8. PubMed ID: 34761338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation.
    Yang F; Xu J; Li H; Tan M; Xiong X; Sun Y
    Nat Commun; 2019 Mar; 10(1):1382. PubMed ID: 30918250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of β-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer.
    Pan KF; Lee WJ; Chou CC; Yang YC; Chang YC; Chien MH; Hsiao M; Hua KT
    EMBO J; 2021 Feb; 40(4):e105450. PubMed ID: 33347625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of β-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression.
    Sabbineni H; Verma A; Artham S; Anderson D; Amaka O; Liu F; Narayanan SP; Somanath PR
    Biochem Pharmacol; 2019 Jun; 164():205-215. PubMed ID: 30991049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover.
    Gao F; Artham S; Sabbineni H; Al-Azayzih A; Peng XD; Hay N; Adams RH; Byzova TV; Somanath PR
    Cell Mol Life Sci; 2016 Oct; 73(20):3917-33. PubMed ID: 27113546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPM4 regulates Akt/GSK3-β activity and enhances β-catenin signaling and cell proliferation in prostate cancer cells.
    Sagredo AI; Sagredo EA; Cappelli C; Báez P; Andaur RE; Blanco C; Tapia JC; Echeverría C; Cerda O; Stutzin A; Simon F; Marcelain K; Armisén R
    Mol Oncol; 2018 Feb; 12(2):151-165. PubMed ID: 28614631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
    Park N; Baek HS; Chun YJ
    PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF and the regulation of tight junctions in human prostate cancer cells.
    Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2014 Jul; 32(1):213-24. PubMed ID: 24858137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
    Shimobaba S; Taga S; Akizuki R; Hichino A; Endo S; Matsunaga T; Watanabe R; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1170-8. PubMed ID: 26919807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β-Catenin Pathway upon LPS Stimulation.
    Li J; Yin J; Shen W; Gao R; Liu Y; Chen Y; Li X; Liu C; Xiang R; Luo N
    Anat Rec (Hoboken); 2017 Jul; 300(7):1219-1229. PubMed ID: 28296189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of Akt1/2 suppresses the metastasis of human prostate cancer cells CWR22rv1 in vitro and in vivo.
    Su B; Zhang L; Zhuang W; Zhang W; Chen X
    J Cell Mol Med; 2021 Feb; 25(3):1546-1553. PubMed ID: 33377281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation.
    Goc A; Liu J; Byzova TV; Somanath PR
    Br J Cancer; 2012 Aug; 107(4):713-23. PubMed ID: 22767145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.